Plant Advanced Technologies SA Asset Resilience Ratio
Plant Advanced Technologies SA asset resilience ratio. Plant Advanced Technologies SA (ALPAT) has an Asset Resilience Ratio of 30.95% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Plant Advanced Technologies SA (ALPAT) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Plant Advanced Technologies SA (2009–2022)
Asset resilience ratio of Plant Advanced Technologies SA from 2009 to 2022. This chart shows how Plant Advanced Technologies SA's Asset Resilience Ratio has changed over time. Read ALPAT liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Plant Advanced Technologies SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Plant Advanced Technologies SA total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €5.29 Million | 30.95% |
| Total Liquid Assets | €5.29 Million | 30.95% |
Asset Resilience Insights
- Very High Liquidity: Plant Advanced Technologies SA maintains exceptional liquid asset reserves at 30.95% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Plant Advanced Technologies SA Industry Peers by Asset Resilience Ratio
Compare Plant Advanced Technologies SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX |
Biotechnology | 15.95% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 2.50% |
|
Ascendis Pharma AS
NASDAQ:ASND |
Biotechnology | 0.00% |
|
Summit Therapeutics PLC
NASDAQ:SMMT |
Biotechnology | 36.07% |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
Biotechnology | 62.31% |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
Biotechnology | 0.00% |
|
Verona Pharma PLC ADR
NASDAQ:VRNA |
Biotechnology | 0.00% |
|
3SBio Inc
F:83B |
Biotechnology | 10.64% |
Plant Advanced Technologies SA Asset Resilience Ratio by Year (2009–2022)
Plant Advanced Technologies SA asset resilience ratio by year from 2009 to 2022. The table below shows the annual Asset Resilience Ratio data for Plant Advanced Technologies SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 30.95% | €5.29 Million ≈ $6.18 Million |
€17.08 Million ≈ $19.97 Million |
-0.10pp |
| 2021-12-31 | 31.06% | €5.31 Million ≈ $6.21 Million |
€17.11 Million ≈ $20.00 Million |
+0.52pp |
| 2020-12-31 | 30.53% | €5.27 Million ≈ $6.16 Million |
€17.27 Million ≈ $20.19 Million |
+40.56pp |
| 2019-12-31 | -10.02% | €-1.39 Million ≈ $-1.63 Million |
€13.89 Million ≈ $16.24 Million |
-10.06pp |
| 2013-12-31 | 0.04% | €1.68K ≈ $1.96K |
€4.26 Million ≈ $4.98 Million |
-0.01pp |
| 2012-12-31 | 0.05% | €1.68K ≈ $1.96K |
€3.54 Million ≈ $4.14 Million |
-0.01pp |
| 2011-12-31 | 0.06% | €1.68K ≈ $1.96K |
€2.88 Million ≈ $3.37 Million |
+0.01pp |
| 2010-12-31 | 0.05% | €1.68K ≈ $1.96K |
€3.22 Million ≈ $3.76 Million |
+0.04pp |
| 2009-12-31 | 0.01% | €80.00 ≈ $93.53 |
€1.02 Million ≈ $1.19 Million |
-- |
About Plant Advanced Technologies SA
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. … Read more